Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tarek Ajami

Showing results (11-20 of 48) with videos related to

Pageof 5
Sort By:
Urologic Oncology|February 28, 2025
Association of metabolic syndrome and chronic kidney disease with nonmuscle invasive bladder cancer recurrence and progressionChristabel Egemba, Sneha Kapil, Tarek Ajami, et al.
The Prostate|June 29, 2022
Gene variation impact on prostate cancer progression: Lymphocyte modulator, activation, and cell adhesion gene variant contributionSergi Casadó-Llombart, Tarek Ajami, Marta Consuegra-Fernández, et al.
Journal of Cancer Policy|November 26, 2023
Cancer care pathways across seven countries in Europe: What are the current obstacles? And how can artificial intelligence help?Iman Hesso, Reem Kayyali, Lithin Zacharias, et al.
JMIR Cancer|October 10, 2024
Artificial Intelligence for Optimizing Cancer Imaging: User Experience StudyIman Hesso, Lithin Zacharias, Reem Kayyali, et al.
Biomed Research International|September 16, 2020
Results and Lessons Learned on Robotic Assisted Kidney TransplantationMireia Musquera, Lluis Peri, Tarek Ajami, et al.
BJUI Compass|March 14, 2024
Incidental prostate cancer after holmium laser enucleation of the prostate: Critical analysis of independent risk factors and impact on surgical outcomesJoao G Porto, Ruben Blachman-Braun, Tarek Ajami, et al.
Urologic Oncology|May 24, 2024
Combined holmium laser enucleation of the prostate with high-intensity focused ultrasound in treating patients with localized prostate cancer in a prostate with volume > 60 g: Oncological and functional outcomes from single-institution studyTarek Ajami, Ruben Blachman-Braun, Joao G Porto, et al.
International Journal of Molecular Sciences|October 14, 2022
Cell-Free DNA as a Prognostic Biomarker for Monitoring Muscle-Invasive Bladder CancerRaquel Carrasco, Mercedes Ingelmo-Torres, Ascensión Gómez, et al.
Radiation Oncology (London, England)|October 9, 2023
Cancer care at the time of the fourth industrial revolution: an insight to healthcare professionals' perspectives on cancer care and artificial intelligenceIman Hesso, Reem Kayyali, Debbie-Rose Dolton, et al.
World Journal of Urology|March 12, 2025
Use of biochemical and imaging criteria for selecting patients for prostate biopsy in recurrence risk assessment post-HIFU therapyTarek Ajami, Adam Williams, Jonathan T Ryan, et al.
Pageof 5

Showing results (11-20 of 48) with videos related to

Sort By:
Pageof 5
Urologic Oncology|February 28, 2025
Association of metabolic syndrome and chronic kidney disease with nonmuscle invasive bladder cancer recurrence and progressionChristabel Egemba, Sneha Kapil, Tarek Ajami, et al.
The Prostate|June 29, 2022
Gene variation impact on prostate cancer progression: Lymphocyte modulator, activation, and cell adhesion gene variant contributionSergi Casadó-Llombart, Tarek Ajami, Marta Consuegra-Fernández, et al.
Journal of Cancer Policy|November 26, 2023
Cancer care pathways across seven countries in Europe: What are the current obstacles? And how can artificial intelligence help?Iman Hesso, Reem Kayyali, Lithin Zacharias, et al.
JMIR Cancer|October 10, 2024
Artificial Intelligence for Optimizing Cancer Imaging: User Experience StudyIman Hesso, Lithin Zacharias, Reem Kayyali, et al.
Biomed Research International|September 16, 2020
Results and Lessons Learned on Robotic Assisted Kidney TransplantationMireia Musquera, Lluis Peri, Tarek Ajami, et al.
BJUI Compass|March 14, 2024
Incidental prostate cancer after holmium laser enucleation of the prostate: Critical analysis of independent risk factors and impact on surgical outcomesJoao G Porto, Ruben Blachman-Braun, Tarek Ajami, et al.
Urologic Oncology|May 24, 2024
Combined holmium laser enucleation of the prostate with high-intensity focused ultrasound in treating patients with localized prostate cancer in a prostate with volume > 60 g: Oncological and functional outcomes from single-institution studyTarek Ajami, Ruben Blachman-Braun, Joao G Porto, et al.
International Journal of Molecular Sciences|October 14, 2022
Cell-Free DNA as a Prognostic Biomarker for Monitoring Muscle-Invasive Bladder CancerRaquel Carrasco, Mercedes Ingelmo-Torres, Ascensión Gómez, et al.
Radiation Oncology (London, England)|October 9, 2023
Cancer care at the time of the fourth industrial revolution: an insight to healthcare professionals' perspectives on cancer care and artificial intelligenceIman Hesso, Reem Kayyali, Debbie-Rose Dolton, et al.
World Journal of Urology|March 12, 2025
Use of biochemical and imaging criteria for selecting patients for prostate biopsy in recurrence risk assessment post-HIFU therapyTarek Ajami, Adam Williams, Jonathan T Ryan, et al.
Pageof 5